Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics, Inc. (CAPR) is a healthcare company (biotechnology) based in the United States. The share price is $8.91, up 7.35% on the day, which values the company at $518.05M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$8.91+7.35% today
Market value
$518.05M
Funk Score
43/100
200-week average
$10.8518% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Capricor Therapeutics, Inc. in more detail

CAPR trades at -6.2× next year's expected earnings. It sits 18% below its 200-week average of $10.85.

Its Funk Score is 43 out of 100 (financial strength 4.3, profitability 3.7, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold CAPR, including Peter Kolchinsky (0.3% of the portfolio).

Superinvestors holding CAPR

1 of the investors tracked here report a position in their latest 13F filing.

Capricor Therapeutics, Inc. (CAPR): questions and answers

What is CAPR's PEG ratio?

Capricor Therapeutics, Inc.'s PEG ratio is 0.38 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Capricor Therapeutics, Inc.'s market cap?

Capricor Therapeutics, Inc. is valued at $518.05M at a share price of $8.91.

Is CAPR above its 200-week moving average?

No. CAPR is 17.9% below its 200-week average of $10.85. Long-term investors watch that line because strong companies rarely trade below it for long.

Does CAPR pay a dividend?

Capricor Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own CAPR?

In their latest quarterly filings, Peter Kolchinsky (0.3% of the portfolio) hold CAPR. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Capricor Therapeutics, Inc. (CAPR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CAPR

Underlying data: Yahoo Finance; company filings with the SEC.